“The healthcare industry is witnessing a paradigm shift from traditional devices to more sophisticated and programmed ones. Growing demand for noninvasive procedures, sophisticated drug delivery techniques, and improved patient monitoring solutions are propelling the growth of this market. Companies are increasingly focusing on investing in R&D activities for the development of the smart pills technology in order to meet consumer expectations and to help in the treatment of various diseases.
The smart pills market is segmented on the basis of applications and regions. On the basis of applications, capsule endoscopy accounted for the largest share of the smart pills market in 2014. On the basis of regions, North America is expected to grow at the highest CAGR during the forecast period. The high growth of this region can be attributed to the favorable reimbursement scenario, FDA approvals for smart pills, and investment by government and other agencies.
The smart pills market has few players as two major segments of the market are under R&D phase. The companies in this market focus on growth strategies such as new product launches; agreements, partnerships, collaborations, and others (approvals and expansion) to increase their customer base.
The major players in the global smart pills market include CapsoVision, Inc. (U.S.), Given Imaging, Inc. (Israel), Medimetrics S.A. de C.V. (Mexico), Olympus Corporation (Japan), and Bio-Images Research Limited (U.K.).
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios and services offered by the 10 major players in the smart pills market. The report analyzes the smart pills technology across geographies
• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the smart pills market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the smart pills market across geographies
• Market Diversification: Extensive information about new products and services, untapped geographies, recent developments, and investments in the smart pills market
• Competitive Assessment: In-depth assessment of strategies, products, and services of the leading players in the smart pills market
”
“TABLE OF CONTENTS
1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY & PRICING 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 18
2.1.1 SECONDARY RESEARCH 18
2.1.2 KEY DATA FROM SECONDARY SOURCES 18
2.1.3 PRIMARY RESEARCH 19
2.1.3.1 Key data from primary sources 20
2.1.3.2 Key insights from primary sources 21
2.2 MARKET SIZE ESTIMATION METHODOLOGY 21
2.2.1 MARKET FORECAST METHODOLOGY 23
2.2.2 MARKET DATA VALIDATION AND TRIANGULATION 23
2.2.3 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 29
4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE SMART PILLS MARKET 29
4.2 GLOBAL SMART PILLS MARKET, BY APPLICATION 30
4.3 GROWTH RATE ACROSS GEOGRAPHIES 31
4.4 SMART PILLS MARKET: LIFE CYCLE ANALYSIS, BY GEOGRAPHY 32
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 34
5.2 MARKET SEGMENTATION 34
5.2.1 SMART PILLS MARKET, BY APPLICATION 34
5.2.2 SMART PILLS MARKET, BY GEOGRAPHY 35
5.3 MARKET DYNAMICS 36
5.4 DRIVERS 36
5.4.1 FAVORABLE REIMBURSEMENT SCENARIO 36
5.4.2 PATIENT PREFERENCE FOR MINIMALLY INVASIVE SURGERIES 37
5.4.3 TECHNOLOGICAL ADVANCEMENTS IN CAPSULE ENDOSCOPES 37
5.4.4 INCREASE IN INCIDENCE OF COLON CANCER 37
5.4.5 BOWEL SCOPE SCREENING IS EXPECTED TO HAVE A POSITIVE IMPACT ON THE ENDOSCOPY MARKET IN THE U.K. 39
5.4.6 GROWTH IN AGING POPULATION 40
5.5 RESTRAINTS 41
5.5.1 TECHNOLOGICAL LIMITATIONS IN TERMS OF TAKING IMAGES OF A PARTICULAR SITE AND RETENTION OF CAPSULE 41
5.5.2 INCREASING TECHNOLOGICAL SOPHISTICATION IN SMART PILLS TO INCREASE THEIR COST 42
5.6 OPPORTUNITIES 42
5.6.1 NEED FOR A RAPID DRUG DEVELOPMENT PROCESS 42
5.7 PORTER’S FIVE FORCES ANALYSIS 43
5.7.1 THREAT OF NEW ENTRANTS 44
5.7.2 THREAT OF SUBSTITUTES 44
5.7.3 BARGAINING POWER OF BUYERS 44
5.7.4 BARGAINING POWER OF SUPPLIERS 45
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 45
6 SMART PILLS TECHNOLOGY MARKET, BY APPLICATION 46
6.1 INTRODUCTION 47
6.2 CAPSULE ENDOSCOPES 48
6.2.1 OVERVIEW 48
6.2.2 CAPSULE ENDOSCOPES: COMPONENTS 48
6.2.2.1 Components 49
6.2.3 PILLCAM COLON BY GIVEN IMAGING 50
6.2.3.1 Interactive colon exam comparison tool 51
6.2.4 CURRENTLY MARKETED PRODUCTS WITH SPECIFICATIONS 52
6.2.5 CAPSULE ENDOSCOPES MARKET SIZE 53
6.3 SMART PILLS FOR PATIENT MONITORING 56
6.3.1 SMART PILLS FOR PATIENT MONITORING: OVERVIEW 56
6.3.2 PROTEUS DIGITAL HEALTH 56
6.3.3 SMART PILLS FOR PATIENT MONITORING: MARKET SIZE 57
6.3.4 SMART PILLS FOR PATIENT MONITORING: FUTURE POTENTIAL 57
6.4 SMART PILLS FOR DRUG DELIVERY 58
6.4.1 SMART PILLS FOR DRUG DELIVERY: OVERVIEW 58
6.4.2 INTELLICAP SYSTEM BY MEDIMETRICS 58
6.4.3 SMART PILLS FOR DRUG DELIVERY: MARKET SIZE 59
6.4.4 SMART PILLS FOR DRUG DELIVERY: FUTURE POTENTIAL 60
7 RESEARCH LANDSCAPE 61
7.1 THE MELODY PROJECT 61
7.2 EDIBLE BATTERY TO TARGET HEALTH SENSORS AND DRUG DELIVERY 62
7.3 LASER PILL FOR ESOPHAGUS IMAGING 62
7.4 MAARS REMOTE-CONTROLLED MAGNETIC CAPSULE 63
7.5 DESIGN AND IMPLEMENTATION OF MINIATURIZED CAPSULES FOR AUTO-FLUORESCENCE DETECTION WITH POSSIBLE APPLICATIONS IN BOWEL DISEASE 63
7.6 DETECTING A SECRETED GASTRIC CANCER BIOMARKER MOLECULE BY TARGETED NANOPARTICLES FOR REAL-TIME DIAGNOSTICS 64
7.7 MAGNETICALLY ACTUATED SOFT CAPSULE ENDOSCOPE (MASCE) 65
7.8 POWER GENERATION TECHNOLOGY USING BENDABLE THIN FILM NANO-MATERIALS 65
7.9 WIRELESSLY COMMUNICATING CAPSULE PROTOTYPE 66
7.10 DEVELOPMENT OF CMOS SENSORS FOR INCORPORATION IN ENDOSCOPIC CAPSULES FOR CANCER CELLS 66
7.11 VERSATILE ENDOSCOPIC CAPSULE FOR GASTROINTESTINAL TUMOR RECOGNITION AND THERAPY: VECTOR 67
7.12 NOVEL, INNOVATIVE, REMOTE-CONTROLLED DRUG DELIVERY CAPSULE 68
7.13 DRUG DELIVERY WITH MUSCLE 68
8 SMART PILLS MARKET, BY REGION 69
8.1 INTRODUCTION 70
8.2 NORTH AMERICA 72
8.2.1 U.S. 75
8.2.2 CANADA 76
8.3 EUROPE 77
8.3.1 U.K. 80
8.3.2 SPAIN 81
8.3.3 GERMANY 82
8.3.4 FRANCE 83
8.3.5 ITALY 84
8.3.6 REST OF EUROPE 86
8.4 ASIA 87
8.4.1 JAPAN 89
8.4.2 CHINA 91
8.4.3 INDIA 92
8.4.4 REST OF ASIA (ROA) 93
8.5 REST OF THE WORLD (ROW) 94
8.6 PEST ANALYSIS 99
8.6.1 POLITICAL FACTORS 99
8.6.2 ECONOMIC FACTORS 99
8.6.3 SOCIAL FACTORS 100
8.6.4 TECHNOLOGICAL FACTORS 100
9 COMPETITIVE LANDSCAPE 101
9.1 OVERVIEW 101
9.2 R&D INVESTMENT ANALYSIS, SMART PILLS MARKET 102
9.3 COMPETITIVE SITUATION AND TRENDS 103
9.3.1 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 103
9.3.2 NEW PRODUCT LAUNCHES 104
9.4 EXPANSIONS 105
9.5 OTHER DEVELOPMENTS 106
9.6 MERGERS AND ACQUISITIONS 106
10 COMPANY PROFILES 107
10.1 ACAMP 108
10.1.1 BUSINESS OVERVIEW 108
10.1.2 ACAMP: COMPANY SNAPSHOT 108
10.1.3 PRODUCT PORTFOLIO 108
10.2 BIO-IMAGES RESEARCH LTD. 109
10.2.1 BUSINESS OVERVIEW 109
10.2.2 SERVICE OFFERINGS 109
10.2.3 RECENT DEVELOPMENTS 109
10.3 BOSTON SCIENTIFIC CORPORATION 110
10.3.1 BUSINESS OVERVIEW 110
10.3.2 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 110
10.3.3 KEY STRATEGY 111
10.3.3.1 Focus on research and development: 111
10.4 CAPSOVISION, INC. 112
10.4.1 BUSINESS OVERVIEW 112
10.4.2 PRODUCT PORTFOLIO 112
10.4.3 KEY STRATEGY 113
10.4.3.1 Market development: 113
10.4.4 RECENT DEVELOPMENTS 113
10.5 GIVEN IMAGING, INC. 114
10.5.1 BUSINESS OVERVIEW 114
10.5.2 MEDTRONIC, INC.: COMPANY SNAPSHOT 114
10.5.3 PRODUCT PORTFOLIO: 115
10.5.4 KEY STRATEGY 115
10.5.4.1 FDA Approvals: 115
10.5.5 RECENT DEVELOPMENTS 115
10.6 MEDIMETRICS S.A. DE C.V. 116
10.6.1 BUSINESS OVERVIEW 116
10.6.2 PRODUCTS AND SERVICES 116
10.6.3 KEY STRATEGY 116
10.6.3.1 Partnerships and collaborations: 116
10.6.4 RECENT DEVELOPMENTS 117
10.7 OLYMPUS CORPORATION 118
10.7.1 BUSINESS OVERVIEW 118
10.7.2 OLYMPUS CORPORATION: COMPANY SNAPSHOT 118
10.7.3 PRODUCT PORTFOLIO 119
10.7.4 KEY STRATEGY 119
10.7.4.1 New Product Launches 119
10.7.5 RECENT DEVELOPMENTS 119
10.8 PROTEUS DIGITAL HEALTH, INC. 120
10.8.1 BUSINESS OVERVIEW 120
10.8.2 PRODUCT PORTFOLIO 120
10.8.3 KEY STRATEGY 120
10.8.3.1 Partnerships and Collaborations 120
10.8.4 RECENT DEVELOPMENTS 121
11 APPENDIX 122
11.1 INSIGHTS OF INDUSTRY EXPERTS 122
11.2 DISCUSSION GUIDE 123
11.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 125
11.4 AVAILABLE CUSTOMIZATIONS 125
11.5 RELATED REPORTS 126
“
“LIST OF TABLES
TABLE 1 INCREASING INCIDENCE OF THE CANCERS IN MEN GLOBALLY DRIVES THE SMART PILL MARKET 38
TABLE 2 INCREASING INCIDENCE OF THE CANCERS IN WOMEN GLOBALLY DRIVES THE SMART PILL MARKET 38
TABLE 3 COLORECTAL CANCER: ESTIMATED INCIDENCE, MORTALITY AND PREVALENCE WORLDWIDE IN 2012 39
TABLE 4 COUNTRIES WITH HIGHEST INCIDENCE OF COLORECTAL CANCER IN 2012 (BOTH SEXES) 40
TABLE 5 SMART PILLS MARKET SIZE, BY APPLICATION, 2014–2024 ($MILLION) 47
TABLE 6 SMART PILLS MARKET SIZE FOR CAPSULE ENDOSCOPES, BY REGION,
2014–2024 ($MILLION) 54
TABLE 7 CAPSULE ENDOSCOPES MARKET SIZE FOR SMALL INTESTINE, BY REGION,
2014-2024 ($MILLION) 54
TABLE 8 CAPSULE ENDOSCOPES MARKET SIZE FOR COLON, BY REGION,
2014-2024 ($ MILLION) 55
TABLE 9 CAPSULE ENDOSCOPES MARKET SIZE FOR OTHER CAPSULE ENDOSCOPY,
BY REGION, 2014-2024 ($ MILLION) 55
TABLE 10 SMART PILLS MARKET SIZE FOR PATIENT MONITORING, BY REGION,
2014–2024 ($MILLION) 57
TABLE 11 SMART PILLS MARKET SIZE FOR DRUG DELIVERY, BY REGION,
2014–2024 ($MILLION) 59
TABLE 12 SMART PILLS MARKET SIZE, BY REGION, 2012–2024 ($MILLION) 71
TABLE 13 NORTH AMERICA: SMART PILLS MARKET SIZE, BY APPLICATION,
2012–2024 ($MILLION) 73
TABLE 14 NORTH AMERICA: SMART PILLS MARKET SIZE, BY COUNTRY,
2012–2024 ($MILLION) 73
TABLE 15 NORTH AMERICA: CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY,
2012–2024 ($MILLION) 73
TABLE 16 NORTH AMERICA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 74
TABLE 17 NORTH AMERICA: DRUG DELIVERY MARKET SIZE, BY COUNTRY,
2012–2024 ($MILLION) 74
TABLE 18 NORTH AMERICA: PATIENT MONITORING MARKET SIZE, BY COUNTRY,
2012–2024 ($MILLION) 74
TABLE 19 US: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 75
TABLE 20 US: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 76
TABLE 21 CANADA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 76
TABLE 22 CANADA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 77
TABLE 23 EUROPE: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 78
TABLE 24 EUROPE: SMART PILLS MARKET SIZE, BY COUNTRY/REGION,
2012–2024 ($MILLION) 78
TABLE 25 EUROPE: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 78
TABLE 26 EUROPE: CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY/REGION,
2014–2024 ($MILLION) 79
TABLE 27 EUROPE: DRUG DELIVERY MARKET SIZE, BY COUNTRY/REGION,
2012–2024 ($MILLION) 79
TABLE 28 EUROPE: PATIENT MONITORING MARKET SIZE, BY COUNTRY/REGION,
2012–2024 ($MILLION) 80
TABLE 29 UK: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 81
TABLE 30 UK: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 81
TABLE 31 SPAIN: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 82
TABLE 32 SPAIN: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 82
TABLE 33 GERMANY: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 83
TABLE 34 GERMANY: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 83
TABLE 35 FRANCE: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 84
TABLE 36 FRANCE: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 84
TABLE 37 ITALY: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 85
TABLE 38 ITALY: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 85
TABLE 39 ROE: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 86
TABLE 40 ROE: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 86
TABLE 41 ASIA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 87
TABLE 42 ASIA: SMART PILLS MARKET SIZE, BY COUNTRY/REGION, 2012–2024 ($MILLION) 87
TABLE 43 ASIA: CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY/REGION,
2012–2024 ($MILLION) 88
TABLE 44 ASIA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 88
TABLE 45 ASIA: DRUG DELIVERY MARKET SIZE, BY COUNTRY/REGION,
2012–2024 ($MILLION) 88
TABLE 46 ASIA: PATIENT MONITORING MARKET SIZE, BY COUNTRY/REGION,
2012–2024 ($MILLION) 89
TABLE 47 JAPAN: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 90
TABLE 48 JAPAN: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 90
TABLE 49 CHINA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 91
TABLE 50 CHINA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 91
TABLE 51 INDIA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 92
TABLE 52 INDIA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 92
TABLE 53 ROA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 93
TABLE 54 ROA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 93
TABLE 55 ROW: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 94
TABLE 56 ROW: SMART PILLS MARKET SIZE, BY REGION, 2012–2024 ($MILLION) 95
TABLE 57 ROW: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 95
TABLE 58 ROW: CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2012–2024 ($MILLION) 95
TABLE 59 ROW: DRUG DELIVERY MARKET SIZE, BY REGION, 2012–2024 ($MILLION) 96
TABLE 60 ROW: PATIENT MONITORING MARKET SIZE, BY REGION, 2012–2024 ($MILLION) 96
TABLE 61 LATIN AMERICA: SMART PILLS MARKET SIZE, BY APPLICATION,
2012–2024 ($MILLION) 96
TABLE 62 LATIN AMERICA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 97
TABLE 63 PACIFIC COUNTRIES: SMART PILLS MARKET SIZE, BY APPLICATION,
2012–2024 ($MILLION) 97
TABLE 64 PACIFIC COUNTRIES: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012–2024 ($MILLION) 97
TABLE 65 MIDDLE EAST & AFRICA: SMART PILLS MARKET SIZE, BY APPLICATION,
2012–2024 ($MILLION) 98
TABLE 66 MIDDLE EAST & AFRICA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012–2024 ($MILLION) 98
TABLE 67 AGREEMENTS AND COLLABORATIONS, 2012-2014 104
TABLE 68 NEW PRODUCT LAUNCHES, 2012-2014 104
TABLE 69 EXPANSIONS, 2012-2014 105
TABLE 70 OTHER DEVELOPMENTS, 2012-2014 106
TABLE 71 MERGERS AND ACQUISITIONS, 2012-2014 106
TABLE 72 EXCHANGE RATES (USED FOR CONVERSION OF YEN TO USD) 118
“
“LIST OF FIGURES
FIGURE 1 SMART PILLS MARKET SEGMENTATION 14
FIGURE 2 RESEARCH METHODOLOGY DESIGN 17
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 20
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 22
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 22
FIGURE 6 MARKET FORECAST METHODOLOGY 23
FIGURE 7 DATA TRIANGULATION METHODOLOGY 24
FIGURE 8 ROW TO WITNESS THE HIGHEST GROWTH RATE IN THE CAPSULE ENDOSCOPY MARKET FROM 2014 TO 2024 25
FIGURE 9 SMART PILLS MARKET SIZE, BY REGION(2014) 26
FIGURE 10 SMART PILLS MARKET SIZE, BY APPLICATION (2014 VS. 2024) 27
FIGURE 11 SMART PILLS MARKET TO GROW AT A CAGR OF 16% FROM 2014 TO 2020, CAGR OF 23% FROM 2020 TO 2024 29
FIGURE 12 CAPSULE ENDOSCOPY SEGMENT COMMANDED THE LARGEST SHARE OF THE GLOBAL SMART PILLS MARKET, 2014 30
FIGURE 13 ROW TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2020-2024) 31
FIGURE 14 ROW MARKET TO WITNESS HIGHEST GROWTH IN THE NEAR FUTURE(2020-2024) 32
FIGURE 15 SMART PILLS MARKET SEGMENTATION, BY APPLICATION 35
FIGURE 16 SMART PILLS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 36
FIGURE 17 PORTER’S FIVE FORCES ANALYSIS 43
FIGURE 18 CAPSULE ENDOSCOPES DOMINATION IN THE SMART PILLS MARKET IN
2014 VS 2020 53
FIGURE 19 ROW HAS HIGHEST GROWTH IN THE FORECASTED PERIOD 2014–2020 ($MILLION) 59
FIGURE 20 NORTH AMERICAN MARKET TO WITNESS THE HIGHEST CAGR 70
FIGURE 21 CAPSULE ENDOSCOPY SEGMENT TO DOMINATE THE MARKET IN THE FORECAST PERIOD 71
FIGURE 22 COMPANIES ADOPTED AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS AS THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS 101
FIGURE 23 SMART PILLS MARKET: R&D EXPENDITURE SHARE, BY KEY PLAYER, 2014 102
FIGURE 24 BATTLE FOR MARKET SHARE: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS WAS THE KEY GROWTH STRATEGY 103
FIGURE 25 GEOGRAPHICAL PRESENCE OF THE TOP PLAYERS OF THE SMART PILLS MARKET 107
“
